1,411
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE: Lung Cancer

Incidence, risk factors, and dose-volume relationship of radiation-induced rib fracture after carbon ion radiotherapy for lung cancer

, , , , , , , & show all
Pages 163-166 | Received 21 May 2015, Accepted 23 Aug 2015, Published online: 23 Sep 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Cai Grau, Morten Høyer, Per Rugaard Poulsen, Ludvig Paul Muren, Stine Sofia Korreman, Kari Tanderup, Jacob Christian Lindegaard, Jan Alsner & Jens Overgaard. (2017) Rethink radiotherapy – BIGART 2017. Acta Oncologica 56:11, pages 1341-1352.
Read now

Articles from other publishers (3)

Tang Hexiao, Bai Yuquan, Xiong Lecai, Wei Yanhong, Shen Li, Hu Weidong, Xu Ming, Zhou Xuefeng, Pan Gaofeng, Zhang Li, Zhu Minglin, Tang Zheng, Yang Zetian, Zhou Xiao, Cai Yi, Michael Lanuti & Zhao Jinping. (2021) Knockdown of CENPF inhibits the progression of lung adenocarcinoma mediated by ERβ2/5 pathway. Aging 13:2, pages 2604-2625.
Crossref
A. Schernberg & C. Hennequin. (2017) Doses dans les organes à risque en radiothérapie conformationnelle et en radiothérapie en conditions stéréotaxiques : os et moelle osseuse. Cancer/Radiothérapie 21:6-7, pages 619-625.
Crossref
Junichi Saitoh. (2017) To Overcome Radiation Resistance. The KITAKANTO Medical Journal The Kitakanto Medical Journal 67:4, pages 359-360.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.